WTO proposal for Covid diagnostics and therapeutics waiver is abandoned; Novo Nordisk’s diabetes drug Ozempic cuts risk of kidney disease progression, trial shows

Taking stock of the drug industry, from the lab to the medicine chest

March 5, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

APStock STAT+ | WTO proposal for Covid diagnostics and therapeutics waiver is abandoned The proposal was furiously opposed by the pharmaceutical industry, with help from some countries where drugmakers have global headquarters. By Ed Silverman STAT+ | Novo Nordisk's diabetes drug Ozempic cuts risk of kidney disease progression, trial shows A Novo Nordisk study showed that its diabetes drug Ozempic lowered the risk that patients with kidney disease would see progression. By Andrew Joseph First over-the-counter birth control pill in U.S. begins shipping to stores Manufacturer Perrigo said it has begun shipping its over-the-counter birth control pill, Opill, to major retailers and pharmacies. By Associated Press

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser